Literature DB >> 11747326

Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy.

S Faithfull1, J Corner, L Meyer, R Huddart, D Dearnaley.   

Abstract

This study reports results from a randomised controlled trial of nurse-led care and was designed to determine whether nurse-led follow up improved patients morbidity and satisfaction with care in men treated with radical radiotherapy for prostate and bladder cancer. The aim was to compare outcomes in terms of toxicity, symptoms experienced, quality of life, satisfaction with care and health care costs, between those receiving nurse-led care and a group receiving standard care. The study population was of men prescribed radical radiotherapy (greater than 60 Gy). Participants completed self-assessment questionnaires for symptoms and quality of life within the first week of radiotherapy treatment, at week 3, 6 and 12 weeks from start of radiotherapy. Satisfaction with clinical care was also assessed at 12 weeks post-treatment. Observer-rated RTOG toxicity scores were recorded pre-treatment, weeks 1, 3, 6 and 12 weeks from start of radiotherapy. The results presented in this paper are on 115 of 132 (87%) of eligible men who agreed to enter the randomised trial. 6 men (4%) refused and 11 (8%) were missed for inclusion in the study. Data were analysed as a comparison at cross-sectional time points and as a general linear model using multiple regression. There was no significant difference in maximum symptom scores over the time of the trial between nurse-led follow-up care and conventional medical care. Differences were seen in scores in the initial self assessment of symptoms (week 1) that may have been as a result of early nursing intervention. Those men who had received nurse-led care were significantly more satisfied (P < 0.002) at 12 weeks and valued the continuity of the service provided. There were also significant (P < 0.001) cost benefits, with a 31% reduction in costs with nurse-led, compared to medically led care. Evidence from this study suggests that a specialist nurse is able to provide safe follow up for men undergoing radiotherapy. The intervention focused on coping with symptoms, and provided continuity of care and telephone support. Further work is required to improve the management of patients during and after radiotherapy.

Entities:  

Mesh:

Year:  2001        PMID: 11747326      PMCID: PMC2364007          DOI: 10.1054/bjoc.2001.2173

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  12 in total

1.  Working with families caring for a relative with schizophrenia: the evolving role of the community psychiatric nurse.

Authors:  C Brooker; C Butterworth
Journal:  Int J Nurs Stud       Date:  1991       Impact factor: 5.837

Review 2.  The nursing role in radiation oncology: symptom management of acute and chronic reactions.

Authors:  R A Strohl
Journal:  Oncol Nurs Forum       Date:  1988 Jul-Aug       Impact factor: 2.172

3.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

Authors:  J D Cox; J Stetz; T F Pajak
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

4.  Comparison of two quality-of-life instruments for cancer patients: the functional assessment of cancer therapy-general and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30.

Authors:  G Kemmler; B Holzner; M Kopp; M Dünser; R Margreiter; R Greil; B Sperner-Unterweger
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

5.  A randomized clinical trial of early hospital discharge and home follow-up of very-low-birth-weight infants.

Authors:  D Brooten; S Kumar; L P Brown; P Butts; S A Finkler; S Bakewell-Sachs; A Gibbons; M Delivoria-Papadopoulos
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

6.  Posttreatment follow-up of radiation oncology patients in a managed care environment.

Authors:  M L Steinberg; C M Rose
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-04-01       Impact factor: 7.038

7.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

8.  Supportive therapy in radiation oncology.

Authors:  M Rotman; L Rogow; G DeLeon; N Heskel
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

9.  'Just grin and bear it and hope that it will go away': coping with urinary symptoms from pelvic radiotherapy.

Authors:  S Faithfull
Journal:  Eur J Cancer Care (Engl)       Date:  1995-12       Impact factor: 2.520

10.  Who should follow up cancer patients? Nurse specialist based outpatient care and the introduction of a phone clinic system.

Authors:  N D James; D Guerrero; M Brada
Journal:  Clin Oncol (R Coll Radiol)       Date:  1994       Impact factor: 4.126

View more
  19 in total

Review 1.  [Supportive care in radiation oncology].

Authors:  Luis Alberto Pérez Romasanta; Felipe Calvo Manuela
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

2.  A mixed-method evaluation of nurse-led community-based supportive cancer care.

Authors:  D M Howell; J Sussman; J Wiernikowski; N Pyette; D Bainbridge; M O'Brien; T Whelan
Journal:  Support Care Cancer       Date:  2008-03-12       Impact factor: 3.603

Review 3.  Telephone follow-up, initiated by a hospital-based health professional, for postdischarge problems in patients discharged from hospital to home.

Authors:  P Mistiaen; E Poot
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

4.  Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial.

Authors:  Sally Moore; Jessica Corner; Jo Haviland; Mary Wells; Emma Salmon; Charles Normand; Mike Brada; Mary O'Brien; Ian Smith
Journal:  BMJ       Date:  2002-11-16

Review 5.  Psychosocial interventions for reducing fatigue during cancer treatment in adults.

Authors:  Martine Margaretha Goedendorp; Marieke F M Gielissen; Constantijn A H H V M Verhagen; Gijs Bleijenberg
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

6.  Primary versus Tertiary Care Follow-Up of Low-Risk Differentiated Thyroid Cancer: Real-World Comparison of Outcomes and Costs for Patients and Health Care Systems.

Authors:  Syed Ali Imran; Karen Chu; Murali Rajaraman; Drew Rajaraman; Sunita Ghosh; Sarah De Brabandere; Stephanie M Kaiser; Stan Van Uum
Journal:  Eur Thyroid J       Date:  2018-11-22

7.  Follow-up care for men with prostate cancer and the role of primary care: a systematic review of international guidelines.

Authors:  H M McIntosh; R D Neal; P Rose; E Watson; C Wilkinson; D Weller; C Campbell
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640

8.  Nurse-led follow-up of patients after oesophageal or gastric cardia cancer surgery: a randomised trial.

Authors:  E M L Verschuur; E W Steyerberg; H W Tilanus; S Polinder; M-L Essink-Bot; K T C Tran; A van der Gaast; L P S Stassen; E J Kuipers; P D Siersema
Journal:  Br J Cancer       Date:  2008-12-09       Impact factor: 7.640

9.  A Pilot Trial Using Telemedicine in Radiation Oncology: The Future of Health Care Is Virtual.

Authors:  Ryan C Miller; Brittany A Simone; Joseph F Lombardo; James Taylor; Kamila Nowak-Choi; Kevin Ko; Linda Ferguson; Ann Donnelly; Ayesha S Ali; Wenyin Shi; Adam P Dicker; Nicole L Simone
Journal:  Telemed Rep       Date:  2021-06-14

10.  Follow-up strategies following completion of primary cancer treatment in adult cancer survivors.

Authors:  Beverley L Høeg; Pernille E Bidstrup; Randi V Karlsen; Anne Sofie Friberg; Vanna Albieri; Susanne O Dalton; Lena Saltbæk; Klaus Kaae Andersen; Trine Allerslev Horsboel; Christoffer Johansen
Journal:  Cochrane Database Syst Rev       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.